Preparation, characterization, and evaluation of amino acid modified magnetic nanoparticles: drug delivery and MRI contrast agent applications

Pharm Dev Technol. 2018 Dec;23(10):1156-1167. doi: 10.1080/10837450.2018.1536995. Epub 2018 Nov 9.

Abstract

This study is a report about the synthesis iron oxide magnetic nanoparticles (IONPs) which modified with positive and negative charged amino acids (AAs). l-Arginine (Arg) and l-aspartic acid (Asp) which have of guanidinium and carboxylic acid groups, respectively, were selected for this study. After loading chrysin in amino acids modified iron oxide magnetic nanoparticles (F@AAs@Chrysin NPs), it was characterized by XRD, TGA, FTIR, VSM, and TEM techniques. Finally, MTT assays on HFF-2 and HEK-293 cell lines were performed for determination of biocompatibility of AA coated IONPs. The results show that, the ζ-potential and average size of F@Arg@chrysin NPs and F@Asp@chrysin NPs were to -3.87, -2.12 mV, 18.75 ± 2.40 (mean ± SD (n = 50)) nm, and 19.86 ± 2.22 (mean ± SD (n = 48)) nm, respectively. Also, the results indicated that these F@AAs@Chrysin NPs were appropriate for delivery of chrysin. Furthermore, the phantom MRI studies showed the IONPs can be used as contrast agent for the revealing of tumor.

Keywords: MRI; Magnetic nanoparticles; chrysin; drug delivery; hemolysis; theranostic.

MeSH terms

  • Amino Acids / chemistry*
  • Cell Survival
  • Contrast Media / chemistry*
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods*
  • Flavonoids / administration & dosage
  • HEK293 Cells
  • Hemolysis
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Magnetite Nanoparticles / chemistry*
  • Neoplasms / diagnostic imaging

Substances

  • Amino Acids
  • Contrast Media
  • Drug Carriers
  • Flavonoids
  • Magnetite Nanoparticles
  • chrysin